Momenta Pharmaceuticals, Inc. Contracts & Agreements
141 Contracts & Agreements
- Business Finance (22 contracts)
- Business Operations (9)
- Human Resources (66)
- Intellectual Property (2)
- Mergers & Acquisitions (1)
- Real Estate (16)
- Uncategorized (25)
- Agreement and Plan of Merger, dated as of August 19, 2020, by and among Momenta Pharmaceuticals, Inc., Johnson & Johnson, and Vigor Sub, Inc (Filed With SEC on August 19, 2020)
- Retention Agreement, dated as of August 19, 2020, by and between Momenta Pharmaceuticals, Inc. and Santiago Arroyo (Filed With SEC on August 19, 2020)
- Retention Agreement, dated as of August 19, 2020, by and between Momenta Pharmaceuticals, Inc. and Young Kwon (Filed With SEC on August 19, 2020)
- Retention Agreement, dated as of August 19, 2020, by and between Momenta Pharmaceuticals, Inc. and Anthony Manning (Filed With SEC on August 19, 2020)
- Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (Filed With SEC on August 10, 2020)
- Agreement dated July 10, 2020, by and between Momenta Pharmaceuticals, Inc. and Sandoz AG (Filed With SEC on August 10, 2020)
- Description of Capital Stock (Filed With SEC on February 27, 2020)
- Settlement Agreement, dated December 10, 2019, by and between the Registrant, Sandoz Inc. and The Hospital Authority of Metropolitan Government of Nashville and Davidson County,... (Filed With SEC on February 27, 2020)
- Amendment No. 6, dated November 30, 2018, to the Collaboration and License Agreement, dated June 13, 2007, by and between Sandoz AG and the Registrant, as amended (Filed With SEC on February 27, 2020)
- Underwriting Agreement, dated December 11, 2019, among the Company, Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC (Filed With SEC on December 12, 2019)
- Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan, as amended and restated (Filed With SEC on August 7, 2019)
- Seventh Amendment To and Partial Termination of Lease Agreement, dated July 31, 2019, by and between Momenta Pharmaceuticals, Inc. and BMR-Rogers Street LLC (Filed With SEC on August 2, 2019)
- Executive Employment Agreement, dated May 15, 2017, by and between Momenta Pharmaceuticals, Inc. and Santiago Arroyo, as amended (Filed With SEC on May 3, 2019)
- Executive Employment Agreement, dated July 29, 2011, by and between Momenta Pharmaceuticals, Inc. and Young Kwon, as amended (Filed With SEC on May 3, 2019)
- Executive Employment Agreement, dated May 9, 2016, by and between Momenta Pharmaceuticals, Inc. and Anthony Manning, as amended (Filed With SEC on May 3, 2019)
- Executive Employment Agreement, dated April 16, 2019, by and between Momenta Pharmaceuticals, Inc. and Michelle Robertson (Filed With SEC on April 19, 2019)
- Separation and Release Agreement between the Registrant and Scott M. Storer, dated November 5, 2018 (Filed With SEC on February 22, 2019)
- Separation and Release Agreement between the Registrant and Ganesh V. Kaundinya, dated October 5, 2018 (Filed With SEC on February 22, 2019)
- Separation and Release Agreement between the Registrant and Bruce A. Leicher, dated October 5, 2018 (Filed With SEC on February 22, 2019)
- Employment Agreement, as amended, effective as of May 29, 2017, by and between the Registrant and Michelle Robertson (Filed With SEC on February 22, 2019)
- Employment Agreement, as amended, effective as of August 10, 2017, by and between the Registrant and Alejandra Carvajal (Filed With SEC on February 22, 2019)
- Fifth Amendment dated April 24, 2018 to the Lease dated February 5, 2013 by and between BMR-Rogers Street LLC and the Registrant (Filed With SEC on February 22, 2019)
- Underwriting Agreement, dated December 6, 2018, between the Company and Goldman Sachs & Co. LLC (Filed With SEC on December 7, 2018)
- Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (as amended and restated) (Filed With SEC on August 9, 2018)
- Sixth Amendment to and Partial Termination of Lease Agreement, dated August 2, 2018, by and between BMR-Rogers Street LLC and the Registrant (Filed With SEC on August 9, 2018)
- Amendment No. 5, dated November 30, 2017, to the Collaboration and License Agreement, dated June 13, 2007, by and between Sandoz AG and the Registrant, as amended (Filed With SEC on February 26, 2018)
- Letter agreement dated November 15, 2017 to the Lease dated February 5, 2013 by and between BMR-Rogers Street LLC and the Registrant (Filed With SEC on February 26, 2018)
- Fourth Amendment to Lease by and between BMR-Rogers Street LLC and the Registrant, dated as of July 24, 2017 (Filed With SEC on November 1, 2017)
- Letter agreement by and between Sandoz AG and the Registrant, executed as of October 4, 2017 (Filed With SEC on November 1, 2017)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on August 4, 2017)
- AGREEMENT AND GENERAL RELEASE (Filed With SEC on August 4, 2017)
- - 1 - (Filed With SEC on August 4, 2017)
- Non-Employee Director Compensation Summary (Filed With SEC on August 4, 2017)
- MOMENTA PHARMACEUTICALS,INC. 2013 INCENTIVE AWARD PLAN (as amended and restated) ARTICLE 1. PURPOSE (Filed With SEC on August 4, 2017)
- MOMENTA PHARMACEUTICALS, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN (as amended and restated) (Filed With SEC on August 4, 2017)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on May 5, 2017)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on May 5, 2017)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on May 5, 2017)
- MOMENTA PHARMACEUTICALS, INC. EQUITY AWARD RETIREMENT POLICY (Filed With SEC on May 5, 2017)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on February 24, 2017)
- Non-Employee Director Compensation Summary (Filed With SEC on February 24, 2017)
- MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT GRANT NOTICE (Filed With SEC on February 24, 2017)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on February 24, 2017)
- INDUSTRY CONSULTING AGREEMENT (Filed With SEC on February 24, 2017)
- MOMENTA PHARMACEUTICALS, INC. EQUITY AWARD RETIREMENT POLICY (Filed With SEC on December 16, 2016)
- SUBLEASE (Filed With SEC on November 4, 2016)
- Confidential Treatment Requested by Momenta Pharmaceuticals, Inc. (Filed With SEC on August 5, 2016)
- MOMENTA PHARMACEUTICALS,INC. 2013 INCENTIVE AWARD PLAN (as amended and restated, as approved by stockholders on June 22, 2016) ARTICLE 1. PURPOSE (Filed With SEC on August 5, 2016)
- Non-Employee Director Compensation Summary (Filed With SEC on May 6, 2016)
- COLLABORATION AGREEMENT BY AND BETWEEN MOMENTA PHARMACEUTICALS, INC. AND MYLAN IRELAND LIMITED, DATED AS OF JANUARY 8, 2016 (Filed With SEC on May 6, 2016)
- Non-Employee Director Compensation Summary (Filed With SEC on February 26, 2016)
- THIRD AMENDMENT TO LEASE (Filed With SEC on January 5, 2016)
- Amendment to the Collaboration Agreement (Filed With SEC on June 19, 2015)
- Momenta Pharmaceuticals, Inc. 2013 Incentive Award Plan (amended and restated, as approved by stockholders on June 9, 2015) ARTICLE 1. PURPOSE (Filed With SEC on June 10, 2015)
- Momenta Pharmaceuticals, Inc. Common Stock, $0.0001 par value Underwriting Agreement (Filed With SEC on May 20, 2015)
- MOMENTA PHARMACEUTICALS, INC. Common Stock ($0.0001 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT (Filed With SEC on April 21, 2015)
- FOURTH AMENDMENT TO SUBLEASE (Filed With SEC on July 18, 2014)
- MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN (as amended and restated) ARTICLE 1. PURPOSE (Filed With SEC on June 17, 2014)
- MOMENTA PHARMACEUTICALS, INC. 2004 EMPLOYEE STOCK PURCHASE PLAN (as amended and restated) (Filed With SEC on June 17, 2014)
- MOMENTA PHARMACEUTICALS, INC. Common Stock ($0.0001 par value per share) AT-THE-MARKET EQUITY OFFERING SALES AGREEMENT (Filed With SEC on May 6, 2014)
- MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on February 28, 2014)
- SECOND AMENDMENT TO LEASE (Filed With SEC on August 6, 2013)
- MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on June 13, 2013)
- MOMENTA PHARMACEUTICALS, INC. 2013 INCENTIVE AWARD PLAN RESTRICTED STOCK GRANT NOTICE (Filed With SEC on June 13, 2013)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. DEVELOPMENT, LICENSE AND OPTION AGREEMENT BY AND AMONG... (Filed With SEC on February 28, 2012)
- AMENDMENT NO. 3 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on August 5, 2011)
- AMENDMENT NO. 2 TO ASSET PURCHASE AGREEMENT (Filed With SEC on August 5, 2011)
- Non-Employee Director Compensation Summary Effective as of June 14, 2011 (Filed With SEC on August 5, 2011)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on April 1, 2011)
- Signatures on Page Following 1 (Filed With SEC on March 10, 2011)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 23, 2010)
- MOMENTA PHARMACEUTICALS, INC. 4,000,000 Shares Common Stock ($0.0001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2010)
- MOMENTAPHARMACEUTICALS, INC. 2004 EMPLOYEESTOCK PURCHASE PLAN (Filed With SEC on May 6, 2010)
- Non-EmployeeDirector Compensation Summary (Filed With SEC on March 12, 2010)
- Amendment No. 1 to the Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on March 12, 2010)
- Amendment No. 1 to the Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 5, 2009)
- AmendmentNo. 1 to the RestrictedStock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 5, 2009)
- AmendmentNo. 1 to the RestrictedStock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 5, 2009)
- MOMENTAPHARMACEUTICALS, INC. (a Delawarecorporation) 4,000,000 Sharesof Common Stock UNDERWRITINGAGREEMENT (Filed With SEC on September 23, 2009)
- SEVENTH AMENDMENT (Filed With SEC on August 6, 2009)
- AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT (Filed With SEC on August 6, 2009)
- Non-EmployeeDirector Compensation Summary (Filed With SEC on May 7, 2009)
- MOMENTAPHARMACEUTICALS, INC. PLACEMENT AGENCY AGREEMENT (Filed With SEC on December 12, 2008)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 12, 2008)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 5, 2008)
- Confidential Materials omittedand filed separately with the Securities andExchange Commission. Asterisks denote omissions AMENDMENT NO. 1 TO COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on May 9, 2008)
- EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2008)
- SECOND AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on May 9, 2008)
- Executive Officer Compensation Summary (Filed With SEC on March 10, 2008)
- Non-EmployeeDirector Compensation Summary (Filed With SEC on March 10, 2008)
- MOMENTAPHARMACEUTICALS, INC. RestrictedStock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on March 10, 2008)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on February 28, 2008)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on November 8, 2007)
- Purchase Agreement (Filed With SEC on November 8, 2007)
- ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. (Filed With SEC on August 9, 2007)
- TERMINATION OF CONSULTING AGREEMENT (Filed With SEC on May 10, 2007)
- ConfidentialMaterials omitted and filed separately with the Securitiesand Exchange Commission. Asterisks denote omissions. ASSETPURCHASE AGREEMENT datedApril 20, 2007 among... (Filed With SEC on May 10, 2007)
- SIXTHAMENDMENT (Filed With SEC on March 15, 2007)
- FOURTHAMENDMENT (Filed With SEC on March 15, 2007)
- MOMENTA PHARMACEUTICALS,INC. Amended and Restated 2002Stock Incentive Plan (as amendedMarch 7, 2007) (Filed With SEC on March 15, 2007)
- MOMENTA PHARMACEUTICALS, INC. 2004 STOCK INCENTIVE PLAN (as amended May 26,2005 and March 7, 2007) (Filed With SEC on March 15, 2007)
- Executive Officer Compensation Summary (Filed With SEC on March 15, 2007)
- Non-Employee Director Compensation Summary (Filed With SEC on March 15, 2007)
- MOMENTA PHARMACEUTICALS, INC. RestrictedStock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on March 15, 2007)
- MOMENTA PHARMACEUTICALS, INC. Executive Retention Agreement (Filed With SEC on March 15, 2007)
- NovartisPharma AG AND MomentaPharmaceuticals, Inc. STOCKPURCHASE AGREEMENT (Filed With SEC on November 8, 2006)
- Novartis Pharma AG AND Momenta Pharmaceuticals,Inc. INVESTOR RIGHTS AGREEMENT (Filed With SEC on November 8, 2006)
- ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. MEMORANDUMOF UNDERSTANDING (the MOU) July25, 2006 (Filed With SEC on November 8, 2006)
- Confidential Materials omitted and filed separatelywith the Securities and ExchangeCommission. Asterisks denote omissions. THIRDAMENDMENT TO THE OCTOBER 31, 2002 LICENSE (Filed With SEC on November 8, 2006)
- Confidential Materials omitted and filed separatelywith the Securities and ExchangeCommission. Asterisks denote omissions. FIFTHAMENDMENT TO THE NOVEMBER 1, 2002 LICENSE (Filed With SEC on November 8, 2006)
- Confidential Materialsomitted and filed separately with the Securitiesand Exchange Commission. Asterisks denote omissions. Momenta Pharmaceuticals,Inc. 675 West Kendall Street... (Filed With SEC on November 8, 2006)
- EMPLOYMENTAGREEMENT (Filed With SEC on November 8, 2006)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 8, 2006)
- MomentaPharmaceuticals, Inc. Nonstatutory Stock Option Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 8, 2006)
- MomentaPharmaceuticals, Inc. Incentive Stock Option Agreement Granted Under 2004 Stock Incentive Plan, as amended (Filed With SEC on November 8, 2006)
- SUBLEASE (Filed With SEC on November 8, 2006)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on November 8, 2006)
- MOMENTA PHARMACEUTICALS, INC. Restricted Stock Agreement Granted Under 2004 Stock Incentive Plan (Filed With SEC on November 8, 2006)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on September 28, 2006)
- AMENDMENT TO CONSULTING AGREEMENT (Filed With SEC on September 20, 2006)
- ConfidentialMaterials omitted and filed separately with the Securities and Exchange Commission.Asterisks denote omissions. MOMENTA LETTERHEAD (Filed With SEC on August 15, 2006)
- MOMENTAPHARMACEUTICALS, INC. 2004STOCK INCENTIVE PLAN (asamended May 26, 2005) (Filed With SEC on March 16, 2006)
- ExecutiveOfficer Compensation Summary (Filed With SEC on March 16, 2006)
- Non-EmployeeDirector Compensation Summary (Filed With SEC on March 16, 2006)
- MASTER LEASE AGREEMENT dated as of December 30, 2005 (Agreement) (Filed With SEC on March 16, 2006)
- SECONDAMENDMENT TO SUBLEASE (Filed With SEC on March 16, 2006)
- THIRD AMENDMENT TO SUBLEASE (Filed With SEC on March 16, 2006)
- [MomentaPharmaceuticals, Inc. Letterhead] (Filed With SEC on November 14, 2005)
- [MomentaPharmaceuticals, Inc. Letterhead] (Filed With SEC on November 14, 2005)
- FIRSTAMENDMENT TO SUBLEASE (Filed With SEC on November 14, 2005)
- [Momenta Pharmaceuticals, Inc.Letterhead] (Filed With SEC on November 10, 2005)
- RIGHTS AGREEMENT between MOMENTA PHARMACEUTICALS, INC. and AMERICAN STOCK TRANSFER & TRUST COMPANY as Rights Agent Dated as of November 7, 2005 (Filed With SEC on November 8, 2005)
- AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on August 12, 2005)
- 4,827,300 Shares MOMENTA PHARMACEUTICALS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on July 22, 2005)
- AMENDMENT (Filed With SEC on November 12, 2004)
- INDUSTRY CONSULTING AGREEMENT (Filed With SEC on November 12, 2004)
- [CURIS Letterhead] (Filed With SEC on November 12, 2004)
- EXTENSION OF LEASE (Filed With SEC on November 12, 2004)
- EXTENSION OF LEASE (Filed With SEC on November 12, 2004)
- Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge, Massachusetts 02142 (Filed With SEC on November 12, 2004)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission.Asterisks denote omissions. SUBLEASE AGREEMENT BY AND BETWEEN VERTEX PHARMACEUTICALS... (Filed With SEC on November 12, 2004)